Search Results for author: Michael K. Gilson

Found 3 papers, 1 papers with code

Target-Free Compound Activity Prediction via Few-Shot Learning

no code implementations27 Nov 2023 Peter Eckmann, Jake Anderson, Michael K. Gilson, Rose Yu

Predicting the activities of compounds against protein-based or phenotypic assays using only a few known compounds and their activities is a common task in target-free drug discovery.

Activity Prediction Drug Discovery +1

Structure-Based Experimental Datasets for Benchmarking of Protein Simulation Force Fields

no code implementations2 Mar 2023 Chapin E. Cavender, David A. Case, Julian C. -H. Chen, Lillian T. Chong, Daniel A. Keedy, Kresten Lindorff-Larsen, David L. Mobley, O. H. Samuli Ollila, Chris Oostenbrink, Paul Robustelli, Vincent A. Voelz, Michael E. Wall, David C. Wych, Michael K. Gilson

This review article provides an overview of structurally oriented, experimental datasets that can be used to benchmark protein force fields, focusing on data generated by nuclear magnetic resonance (NMR) spectroscopy and room temperature (RT) protein crystallography.

Benchmarking

LIMO: Latent Inceptionism for Targeted Molecule Generation

1 code implementation17 Jun 2022 Peter Eckmann, Kunyang Sun, Bo Zhao, Mudong Feng, Michael K. Gilson, Rose Yu

We corroborate these docking-based results with more accurate molecular dynamics-based calculations of absolute binding free energy and show that one of our generated drug-like compounds has a predicted $K_D$ (a measure of binding affinity) of $6 \cdot 10^{-14}$ M against the human estrogen receptor, well beyond the affinities of typical early-stage drug candidates and most FDA-approved drugs to their respective targets.

Drug Discovery Gaussian Processes +1

Cannot find the paper you are looking for? You can Submit a new open access paper.